| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 | Sep 22, 2023 | Nuvation Bio Inc. | Director | Buy | 100.0 | +5,313,100 | 72.17% | ✗ | $6.7M |
| Feb 19, 2023 | Sep 21, 2023 | Nuvation Bio Inc. | Director | Buy | 100.0 | +5,313,100 | 72.17% | ✗ | $6.7M |
| Mar 31, 2021 | Nov 30, 2021 | Nuvation Bio Inc. | Other | Buy | 87.5 | +488,114 | 1.65% | ✗ | $4.6M |
| Apr 9, 2021 | Apr 13, 2021 | Nuvation Bio Inc. | 10% Owner | Buy | 92.5 | +464,500 | 3.51% | ✗ | $4.6M |
| Jul 6, 2020 | Jul 6, 2020 | Nuvation Bio Inc. | Director | Buy | 100.0 | +390,000 | 100.00% | ✗ | $3.9M |
| Dec 17, 2018 | Jan 10, 2019 | Kura Oncology, Inc. | 10% Owner | Buy | 92.5 | +187,368 | 4.44% | ✗ | $2.6M |
| Dec 11, 2018 | Dec 13, 2018 | Kura Oncology, Inc. | 10% Owner | Buy | 75.0 | +40,538 | 0.97% | ✗ | $563.4K |
| Dec 3, 2018 | Dec 6, 2018 | Kura Oncology, Inc. | 10% Owner | Buy | 77.5 | +119,906 | 0.97% | ✗ | $1.6M |
| May 14, 2018 | May 16, 2018 | aTYR PHARMA INC | 10% Owner | Sell | 17.5 | -3,209,316 | -100.00% | ✗ | $3M |
| Oct 1, 2017 | Dec 14, 2017 | aTYR PHARMA INC | 10% Owner | Buy | 65.0 | +15,775 | 0.49% | ✗ | $86.9K |